MUTO FREDERICK T 4

4 · IONIS PHARMACEUTICALS INC · Filed Jul 19, 2021

Form 4

Period: 2021-07-15

Director

Transactions

Exercise/Conversion
Common Stock
2021-07-15+1,778→ 40,349 total
Exercise/Conversion
Restricted Stock Unit
2021-07-15−5,333→ 13,108 total
Exercise: $0.00→ Common Stock (5,333 underlying)
Exercise/Conversion
Restricted Stock Unit
2021-07-15−889→ 12,219 total
Exercise: $0.00→ Common Stock (889 underlying)
Exercise/Conversion
Restricted Stock Unit
2021-07-15−666→ 11,553 total
Exercise: $0.00→ Common Stock (666 underlying)
Exercise/Conversion
Restricted Stock Unit
2021-07-15−1,778→ 9,775 total
Exercise: $0.00→ Common Stock (1,778 underlying)
Exercise/Conversion
Common Stock
2021-07-15+5,333→ 37,016 total
Exercise/Conversion
Common Stock
2021-07-15+889→ 37,905 total
Exercise/Conversion
Common Stock
2021-07-15+666→ 38,571 total

Holdings

Footnotes (4)

[F1]Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award.
[F2]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
[F3]Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
[F4]Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.

Documents

1 file